Using data from a pre-exposure trial - FEM-PrEP - , we determined the cumulative probabilities of grade 1 + ALT , AST and creatinine and grade 2 + phosphorus toxicities ; ALT/AST toxicities by baseline hepatitis B status ; and change in mean creatinine , phosphorus , ALT and AST levels controlling for TDF-FTC adherence .